Oncology
KEYTRUDA® (pembrolizumab)
Click here to find more information about the different reimbursed indications
BiomarkIT
Practical support for pathologists to help navigate the complex and changing testing landscape
Our goal
Our goal is to translate breakthrough science into innovative oncology medicines to help people with cancer. At MSD Oncology, helping people fight cancer is our passion and supporting accessibility to our cancer medicines is our commitment. Our focus is on pursuing research in immuno-oncology and we are accelerating every step in the journey – from lab to clinic – to potentially bring new hope to people with cancer.